Zobrazeno 1 - 10
of 199
pro vyhledávání: '"Keisuke Kida"'
Autor:
Keisuke Kida, Koshiro Kanaoka, Yoshihiro Miyamoto, Nobuyuki Kagiyama, Tatsuhiro Shibata, Yoshitaka Iwanaga, Shingo Matsumoto, Wataru Fujimoto, Atsushi Kikuchi, Takahito Nasu, Takeshi Ijichi, Syunsuke Ishii
Publikováno v:
Open Heart, Vol 11, Iss 2 (2024)
Background Patients with heart failure exhibiting low systolic blood pressure (SBP) have a poor prognosis. Sacubitril/valsartan reduces cardiovascular events; however, its use in patients with low SBP has not been fully examined. Therefore, in this s
Externí odkaz:
https://doaj.org/article/df1265b93b384733969661f4882201ab
Autor:
Daisaku Kashiwakura, Akiko Hiyama, Masumi Muramatsu, Atsuko Hinotsu, Michiko Takeda, Norio Suzuki, Sachie Akiyama, Sayuri Kurihara, Keisuke Kida
Publikováno v:
JMIR Research Protocols, Vol 13, p e60719 (2024)
BackgroundThe prevalence of heart failure (HF) is increasing worldwide, with the associated mortality rates rising consistently. Preventing HF progression requires adherence to restricted sodium intake alongside sufficient and balanced nutritional co
Externí odkaz:
https://doaj.org/article/dc42c4009dc94f5b8cbc72df51e69785
Autor:
Atsushi Tanaka, Hirotaka Shibata, Takumi Imai, Hisako Yoshida, Motoaki Miyazono, Naohiko Takahashi, Daiju Fukuda, Yosuke Okada, Hiroki Teragawa, Satoru Suwa, Keisuke Kida, Masao Moroi, Isao Taguchi, Shigeru Toyoda, Michio Shimabukuro, Kengo Tanabe, Kenichi Tanaka, Masaomi Nangaku, Koichi Node, the FIVE-STAR trial investigators
Publikováno v:
Cardiovascular Diabetology, Vol 22, Iss 1, Pp 1-11 (2023)
Abstract Background The overactivation of mineralocorticoid receptor (MR) plays a key pathological role in the progression of cardiovascular and renal diseases by promoting pro-inflammatory and pro-fibrotic signaling. Recently, it has been found that
Externí odkaz:
https://doaj.org/article/0116972c43914dcb84485814659f1bb8
Autor:
Shingo Matsumoto, Norihito Nakamura, Masaaki Konishi, Atsushi Shibata, Keisuke Kida, Shunsuke Ishii, Takanori Ikeda, Yuji Ikari
Publikováno v:
ESC Heart Failure, Vol 9, Iss 6, Pp 4077-4087 (2022)
Abstract Aims Given the various effects of sacubitril/valsartan in heart failure, a deeper understanding of atrial natriuretic peptide (ANP) actions is warranted. Natriuresis is a fundamental action of ANP in acute heart failure (AHF), whereas the di
Externí odkaz:
https://doaj.org/article/fdf9a075185344a3b081674c6845405e
Autor:
Miyuki Ito, Daichi Maeda, Yuya Matsue, Yasuyuki Shiraishi, Taishi Dotare, Tsutomu Sunayama, Kazutaka Nogi, Makoto Takei, Tomoya Ueda, Maki Nogi, Satomi Ishihara, Yasuki Nakada, Rika Kawakami, Nobuyuki Kagiyama, Takeshi Kitai, Shogo Oishi, Eiichi Akiyama, Satoshi Suzuki, Masayoshi Yamamoto, Keisuke Kida, Takahiro Okumura, Yuji Nagatomo, Takashi Kohno, Shintaro Nakano, Shun Kohsaka, Tsutomu Yoshikawa, Yoshihiko Saito, Tohru Minamino
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract We clarified the association between changes in the number of foundational medications for heart failure (FMHF) during hospitalization for worsening heart failure (HF) and post-discharge prognosis. We retrospectively analyzed a combined data
Externí odkaz:
https://doaj.org/article/7240510585ad47bd8ce68bcb813c508d
Autor:
Ryosuke Murai, Keisuke Kida, Hiroshi Suzuki, Yasushi Sakata, Takayuki Ise, Shin-ichiro Miura, HIROKAZU KONDO, Yuichi Tamura, Misato Chimura, Tatsunori Taniguchi, Kensuke Takabayashi, Shinji Koba, Hiroyuki Miura, Emi Maekawa, Koki Matsuo, Wataru Fujimoto, Shunsuke Imai, Hideki Origuchi, Akiko Goda, Ryotaro Saita, Atsushi Kikuchi
Publikováno v:
BMJ Open, Vol 13, Iss 8 (2023)
Introduction Cardiac rehabilitation (CR) is strongly recommended as a medical treatment to improve the prognosis and quality of life of patients with heart failure (HF); however, participation rates in CR are low compared with other evidence-based tr
Externí odkaz:
https://doaj.org/article/f7e6450e596e4ed088c8e628c4bcd1c3
Autor:
Kohei Ashikaga, Shunichi Doi, Kihei Yoneyama, Norio Suzuki, Shingo Kuwata, Masashi Koga, Naoya Takeichi, Satoshi Watanabe, Masaki Izumo, Keisuke Kida, Yoshihiro J Akashi
Publikováno v:
JMIR Rehabilitation and Assistive Technologies, Vol 10, p e45247 (2023)
BackgroundNo consensus exists on the efficacy of home-based cardiac rehabilitation (CR) in patients who have undergone transcatheter aortic valve implantation (TAVI). Additionally, there are no reports on home-based cardiac telemonitoring rehabilitat
Externí odkaz:
https://doaj.org/article/d2026fcfe216432297568f5238c05b3e
Autor:
Kazutaka Nogi, Tomoya Ueda, Yuya Matsue, Maki Nogi, Satomi Ishihara, Yasuki Nakada, Rika Kawakami, Nobuyuki Kagiyama, Takeshi Kitai, Shogo Oishi, Eiichi Akiyama, Satoshi Suzuki, Masayoshi Yamamoto, Keisuke Kida, Takahiro Okumura, Yoshihiko Saito
Publikováno v:
ESC Heart Failure, Vol 9, Iss 2, Pp 1061-1070 (2022)
Abstract Aims Acute heart failure (AHF) is a clinical syndrome with a poor prognosis and a major public health concern worldwide. The aim of this study was to investigate whether carperitide administration improves the 1 year prognosis of patients wi
Externí odkaz:
https://doaj.org/article/910bf5a09b5e45029ba6f7900b0b9fed
Autor:
Kenji Yoshioka, Daichi Maeda, Takahiro Okumura, Keisuke Kida, Shogo Oishi, Eiichi Akiyama, Satoshi Suzuki, Masayoshi Yamamoto, Akira Mizukami, Shunsuke Kuroda, Nobuyuki Kagiyama, Tetsuo Yamaguchi, Tetsuo Sasano, Akihiko Matsumura, Takeshi Kitai, Yuya Matsue
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-8 (2022)
Abstract Although intravenous diuretics is a cornerstone of acute heart failure treatment (AHF), its optimal initial dose is unclear. This is a post-hoc analysis of the REALITY-AHF, a prospective multicentre observational registry of AHF. The initial
Externí odkaz:
https://doaj.org/article/17074a1d0344404993549d65c2eade55
Autor:
Kenya Kusunose, Takumi Imai, Atsushi Tanaka, Kaoru Dohi, Kazuki Shiina, Takahisa Yamada, Keisuke Kida, Kazuo Eguchi, Hiroki Teragawa, Yasuchika Takeishi, Nobuyuki Ohte, Hirotsugu Yamada, Masataka Sata, Koichi Node, CANDLE Trial Investigators
Publikováno v:
Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-10 (2021)
Abstract Background Identification of the effective subtypes of treatment for heart failure (HF) is an essential topic for optimizing treatment of the disorder. We hypothesized that the beneficial effect of SGLT2 inhibitors (SGLT2i) on the levels of
Externí odkaz:
https://doaj.org/article/eed530ccf3a24fb4907813a7e5cfe53f